Additionally, platelet agonists such as ADP, TXA2, and thrombin have been detected in cell line supernatants and cancer biopsies (80–82) and interact with platelet receptors P2Y12, TP, and PARs, respectively, to initiate platelet aggregation. The gene discussed is P2RY12; the disease is cancer.